Participate in the Active $UTRx Token ICO Offering!

Raised - UTRx TokensTotal ICO - NaN
  • Presale
  • Soft Cap
  • Hard Cap
Explore the Opportunities

Discover how UTR Therapeutics is pioneering a new era in biotech...

ICO Starts In:

0d 0h 0m 0s

ICO Ends In:

0d 0h 0m 0s

WHAT IS UTR ($UTR)

Empowering Global Health through Innovation and Blockchain.

UTR Therapeutics Inc is an IND Stage biotech company with a first-in-class technology that can overwrite any target of interest. We have proven this robustly in difficult to treat cancers and have filed IND submissions for various cancers to regulatory authorities in the US and outside of the US. This technology is also ready to scale into Neurodegenerative and rare diseases.

  • Decentralized Medical Research Funding
  • AI-Driven Health Innovation Collaboration
  • Tokenized Patient Support and Reward Systems
  • Blockchain-Based Clinical Trial Transparency
  • Community Governance in Healthcare Decisions
  • Global Health Market Access with UTRx Token
WHAY CHOOSE US

Why choose our token?

Mobile payment
make easy

Investment
Projects

Lifetime free
transaction

Protect the
identity

Security your
money

Tokenomics

Allocation of Tokens & Distribution of Funds

1 UTR = 0.004BNB

UTR Therapeutics Inc., an IND-stage biotech company with a first-in-class mRNA overwriting technology, has pioneered breakthrough drugs for deadly cancers. In a bold move to revolutionize its financial ecosystem, UTR decided to transition a portion of its shares for TNBC into blockchain. As part of this transformation, 10 million shares were allocated to blockchain, forming the total supply of UTRX tokens.
To ensure the long-term sustainability and development of the project, 15% of the total UTRX token supply is designated as reserve tokens. These tokens are strategically set aside for development initiatives, partnerships, and ensuring the continued growth of the UTRX ecosystem. This hybrid approach positions UTR as a pioneer, bridging the gap between traditional finance and blockchain technology while maximizing innovation and investor confidence.

Road map

Paths towards the Clinic and Commercialization Roadmap

Discovery Phase

  • Discovery Made
  • Early-stage research
  • Validation to establish
  • proof of feasibility
Q1 2021

Proof of Concept

  • Proof of Concept
  • Studies Confirmed
  • Pre-IND Filed to the FDA
Q1 2022-2023

Validation Phase

  • Validation in
  • Pan Cancers and
  • IND Enablement
Q1 2024

2025 Milestones

  • FDA Response to Resubmission
  • GMP Manufacturing
  • IND Enablement
  • Blockchain Revolution
Q1-Q4 2025

Breakthrough

  • Strategic Liquidity Event (Target IPO)
  • AI-Powered Insights
  • Additional Pipeline Commercialization
Q1 2026-2027

2021

2027

UTRx Token Value Growth By Stage Of Development

Project Milestones, Duration & Cost Estimates

StageObjectiveDurationCost Estimate
FDA Submission & ApprovalFDA and OUS(outside of USA) IND submission already achieved4 years$5M
Ico Initial Launch BuildRaise Money For GMP Manufacturing & Phase 1 Trial1 - 2 months$100 - 200k
GMP ManufacturingPreparation for manufacture of samples for clinical trial (21 patiient trial) 200 000 mg (600 Litres)8 - 10 months$3.5m - 4.5m
IND EnablementProcess of manufacturing, extended data and results6 - 12 months$200 - 400k
Phase I Clinical TrialsApproval of Phase 1 & execution of clinical trial phase 1 - preliminary bio marker endpoint with option for accelerated NDA12 - 16 months$6m - 8m
Ico Exchange LaunchRaise Money For Phase II till Market & Phase manufacture2 - 4 months$400 - 450k
Phase IIProve efficacy and safety of the drug on 50 - 100 patients at a minimum24 - 48 months20 - 50m
Phase IIIValidation of drug superiority, expansion of the label for other applications and combine capability60- 72 months$200 - 300m
Manufacturing and MarketingScale up production and launch drug on market6 - 12 months post-approvalGMP cost x 5 + marketing budget (TNBC)
ICO UTR Token

UTR Token
Details and Sale

  • Total Supply

  • Sold Tokens

    NaN
  • Transaction Limits

    Min: 10 UTRx Tokens / Transaction
    Max: 1,000,000 UTRx Tokens / Transaction
  • Total Supply Token Market Value

    NaN BNB
  • Fund Raised

    NaN BNB
  • Acceptable Currencies

    BNB,ETH, BTC
Token Analytics

Explore Token Analytics

Stay updated with live UTRx token metrics, market activity, and blockchain transactions across trusted platforms.

Our Team

Meet our team

Dr. Chidiebere Awah M.D, Ph.D

Founder/CEO

Daniel Asuzu

IT Lead

Matt Mezer

Business and Operations, MBA

Rebecca Obikunle

Marketing Lead

Chieke Ikenna

Blockchain Developer
FAQ

Frequently asked questions

  • QA : 01 How is this ICO project different from other blockchain ventures?

    UTR Therapeutics Inc. stands apart from other blockchain ventures by integrating cutting-edge biotechnology with decentralized finance. Unlike traditional ICOs that focus solely on digital assets, UTRX tokens represent a groundbreaking hybrid model that bridges biotech innovation with blockchain technology.

    • First-in-class mRNA overwriting technology for treating deadly cancers
    • Real-world asset-backed tokenization, tying blockchain to tangible biotech advancements
    • Strategic allocation of 10 million shares into blockchain, enhancing investor confidence

    By merging biotech breakthroughs with blockchain, UTR is redefining both industries, offering a unique opportunity for investors and stakeholders.
    To learn more about our vision and investment potential,Contact us today.

  • QA : 02 What security measures are in place to protect ICO participants' investments
    and participate in the ICO?

    Security is a top priority for UTRX token holders. To ensure maximum protection, we have integrated our ICO with MetaMask, one of the most trusted and widely used cryptocurrency wallets.

    • MetaMask provides secure, non-custodial storage for UTRX tokens, giving users full control over their assets.
    • Private keys are encrypted and stored locally, ensuring no third party has access to your funds.
    • Blockchain technology ensures transparency, immutability, and protection against fraud.

    By using MetaMask, ICO participants benefit from enterprise-grade security, protecting their investments while enjoying seamless transactions.
    Learn more about how to participate securely in our ICO.

  • QA : 03 What is the purpose and vision behind this ICO project?

    UTR Therapeutics is pioneering the future of cancer treatment with its first-in-class mRNA overwriting technology. By leveraging blockchain through the UTRX token, we aim to democratize access to groundbreaking biotech innovations and enhance investment transparency.

    • Funding the development of next-generation cancer treatments.
    • Bridging traditional finance with blockchain to maximize investor confidence.
    • Creating a sustainable ecosystem for biotech innovation.

    Our vision is to revolutionize the biotech industry by integrating decentralized finance, allowing investors to participate securely and transparently in the future of medicine.
    Learn more about how UTRX is changing the landscape of biotech investments.

  • QA : 04 How can I secure and store my purchased ICO tokens?

    To ensure the safety of your UTRX tokens, we recommend using a secure and reputable wallet. The best option is MetaMask, a widely trusted and decentralized wallet that provides full control over your assets.

    • MetaMask Wallet: Store your UTRX tokens securely in MetaMask, ensuring easy access and full ownership.
    • Private Key & Seed Phrase: Never share your private key or seed phrase with anyone. Store it safely offline to prevent hacks.
    • Hardware Wallets: For maximum security, consider using a hardware wallet like Ledger or Trezor to store your tokens offline.
    • Official Smart Contract Address: Always verify the correct smart contract address before making transactions.

    By following these security practices, you can confidently store and manage your UTRX tokens while ensuring protection against unauthorized access.
    Learn more about securing your digital assets.

  • QA : 05 How can I purchase tokens through your application using MetaMask?

    To purchase tokens through our application using MetaMask, follow these simple steps:

    • Install MetaMask: Download and install MetaMask as a browser extension (Chrome, Firefox, Edge) or mobile app (iOS, Android).
    • Create a Wallet: Set up a new wallet in MetaMask and securely back up your Secret Recovery Phrase.
    • Connect to Our Application: Click the "Connect Wallet" button on our website and approve the connection request in MetaMask.
    • Purchase Tokens: Enter the desired token amount, review the transaction details, and confirm the purchase in MetaMask.
    • Transaction Confirmation: Wait for the blockchain to process the transaction. You can track its status in MetaMask or a blockchain explorer.

    Make sure you have sufficient funds in your MetaMask wallet to cover both the token cost and transaction fees.
    Learn more about purchasing tokens securely.

Contact UTRx Support

+1 (347) 998-7066

token@utrtherapeutics.com

Latest News

Breaking News: UTR Therapeutics Announces the Launching Of UTRX Token on BNB Chain to Revolutionize Biotech Funding

UTR Therapeutics announces the official launch of its new token aimed at revolutionizing healthcare investments.

Read More

How Funding and Mentorship Forged a New Path to Fight Cancer

Read the latest interview of our PI and CEO, Dr. Chidiebere Awah, with Susan Schulz, highlighting UTR Therapeutics Inc.'s journey in advancing novel mRNA-based drugs and breakthrough cancer therapies.

Read More

UTRx is pleased to announce that we have filed 5 new patent application mid February 2025 with the USPTO and 1 PCT filed early February 2025.

UTR Therapeutics solidifies its leadership in cutting-edge cancer therapeutics by filing five new U.S. patents and a major international application.

Read More

UTRx Therapeutics Achieves Major Regulatory Milestone with FDA and OUS IND Submissions

UTR Therapeutics advances clinical readiness with successful IND filings in the U.S. and globally, marking a pivotal step in its cancer therapeutics program.

Read More